ArticlePharmacological reports : PR2022

Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.

Anna Wawruszak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.